Increasing Research and Development Activities to Open Up Lucrative Opportunities for Irritable Bowel Syndrome Treatment Market

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption Analysis
• 4.2. Key Regulations
• 4.3. PESTEL Analysis
• 4.4. Pipeline Assessment
• 4.5. Porter's Analysis
• 4.6. Value Chain Analysis
• 4.7. Promotional Strategies, By Key Manufacturers

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Outlook
  • 5.1.3. Global Gastrointestinal Treatment Market Outlook
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Increase in R&D Spending
  • 5.2.2. Growing Lifestyle Disease Prevalence
  • 5.2.3. Cost of Drug
  • 5.2.4. Adoption Rate of Treatment
  • 5.2.5. Strategic Collaborations
  • 5.2.6. Changes in Regulatory Policies
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Product
  • 6.1.2. By Indication
  • 6.1.3. By Distribution Channel
  • 6.1.4. By Country
• 6.2. 2022 Market Scenario

7. Global Irritable Bowel Syndrome Treatment Market Demand (in Value or Size in US$ Mn) Analysis 2016-2022 and Forecast, 2023-2033

• 7.1. Historical Market Value (US$ Mn) Analysis, 2016-2022
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2016-2022
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2023-2033
  • 8.3.1. Fiber Supplements
  • 8.3.2. Anti-Diarrheal
  • 8.3.3. Anticholinergic and Antispasmodic
  • 8.3.4. Antidepressant
  • 8.3.5. Antibiotics
  • 8.3.6. Alosetron
  • 8.3.7. Lubiprostone
  • 8.3.8. Linaclotide
  • 8.3.9. NHE3
• 8.4. Market Attractiveness Analysis By Product

9. Global Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033, By Indication

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis, By Indication, 2016-2022
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication, 2023-2033
  • 9.3.1. Irritable Bowel Syndrome with Constipation
  • 9.3.2. Irritable Bowel Syndrome with Diarrhea
  • 9.3.3. Irritable Bowel Syndrome with alternating Constipation and Diarrhea
• 9.4. Market Attractiveness Analysis By Indication

10. Global Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis, By Distribution Channel, 2016-2022
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2023-2033
  • 10.3.1. Hospital Pharmacies
  • 10.3.2. Retail Pharmacies
  • 10.3.3. Drug Stores
  • 10.3.4. Online Pharmacies and Stores
  • 10.3.5. Hypermarkets and Supermarkets
• 10.4. Market Attractiveness Analysis By Distribution Channel

11. Global Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033, By Region

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2016-2022
• 11.3. Current and Future Market Value (US$ Mn) Analysis and Forecast, 2023-2033
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. East Asia
  • 11.3.5. South Asia
  • 11.3.6. Oceania
  • 11.3.7. Middle East and Africa (MEA)
• 11.4. Market Attractiveness Analysis By Region

12. North America Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
• 12.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Product
  • 12.3.3. By Indication
  • 12.3.4. By Distribution Channel
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product
  • 12.4.3. By Indication
  • 12.4.4. By Distribution Channel
• 12.5. Market Trends
• 12.6. Drivers and Restraints - Impact Analysis
• 12.7. Key Players - Intensity Mapping
• 12.8. Country Level Analysis & Forecast
  • 12.8.1. U.S. Irritable Bowel Syndrome Treatment Market Analysis
    • 12.8.1.1. Introduction
    • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.1.2.1. By Product
      • 12.8.1.2.2. By Indication
      • 12.8.1.2.3. By Distribution Channel
  • 12.8.2. Canada Irritable Bowel Syndrome Treatment Market Analysis
    • 12.8.2.1. Introduction
    • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.2.2.1. By Product
      • 12.8.2.2.2. By Indication
      • 12.8.2.2.3. By Distribution Channel

13. Latin America Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
• 13.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
  • 13.3.1. By Country
    • 13.3.1.1. Mexico
    • 13.3.1.2. Brazil
    • 13.3.1.3. Argentina
    • 13.3.1.4. Rest of Latin America
  • 13.3.2. By Product
  • 13.3.3. By Indication
  • 13.3.4. By Distribution Channel
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Indication
  • 13.4.4. By Distribution Channel
• 13.5. Market Trends
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Key Players - Intensity Mapping
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. Mexico Irritable Bowel Syndrome Treatment Market Analysis
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By Indication
      • 13.8.1.2.3. By Distribution Channel
  • 13.8.2. Brazil Irritable Bowel Syndrome Treatment Market Analysis
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By Indication
      • 13.8.2.2.3. By Distribution Channel
  • 13.8.3. Argentina Irritable Bowel Syndrome Treatment Market Analysis
    • 13.8.3.1. Introduction
    • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.3.2.1. By Product
      • 13.8.3.2.2. By Indication
      • 13.8.3.2.3. By Distribution Channel

14. Europe Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
• 14.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
  • 14.3.1. By Country
    • 14.3.1.1. Germany
    • 14.3.1.2. Italy
    • 14.3.1.3. France
    • 14.3.1.4. U.K.
    • 14.3.1.5. Spain
    • 14.3.1.6. BENELUX
    • 14.3.1.7. Russia
    • 14.3.1.8. Rest of Europe
  • 14.3.2. By Product
  • 14.3.3. By Indication
  • 14.3.4. By Distribution Channel
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Indication
  • 14.4.4. By Distribution Channel
• 14.5. Market Trends
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Players - Intensity Mapping
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. Germany Irritable Bowel Syndrome Treatment Market Analysis
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Indication
      • 14.8.1.2.3. By Distribution Channel
  • 14.8.2. Italy Irritable Bowel Syndrome Treatment Market Analysis
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Indication
      • 14.8.2.2.3. By Distribution Channel
  • 14.8.3. France Irritable Bowel Syndrome Treatment Market Analysis
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By Indication
      • 14.8.3.2.3. By Distribution Channel
  • 14.8.4. U.K. Irritable Bowel Syndrome Treatment Market Analysis
    • 14.8.4.1. Introduction
    • 14.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.4.2.1. By Product
      • 14.8.4.2.2. By Indication
      • 14.8.4.2.3. By Distribution Channel
  • 14.8.5. Spain Irritable Bowel Syndrome Treatment Market Analysis
    • 14.8.5.1. Introduction
    • 14.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.5.2.1. By Product
      • 14.8.5.2.2. By Indication
      • 14.8.5.2.3. By Distribution Channel
  • 14.8.6. BENELUX Irritable Bowel Syndrome Treatment Market Analysis
    • 14.8.6.1. Introduction
    • 14.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.6.2.1. By Product
      • 14.8.6.2.2. By Indication
      • 14.8.6.2.3. By Distribution Channel
  • 14.8.7. Russia Irritable Bowel Syndrome Treatment Market Analysis
    • 14.8.7.1. Introduction
    • 14.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.7.2.1. By Product
      • 14.8.7.2.2. By Indication
      • 14.8.7.2.3. By Distribution Channel

15. East Asia Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
• 15.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
  • 15.3.1. By Country
    • 15.3.1.1. China
    • 15.3.1.2. Japan
    • 15.3.1.3. South Korea
  • 15.3.2. By Product
  • 15.3.3. By Indication
  • 15.3.4. By Distribution Channel
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Indication
  • 15.4.4. By Distribution Channel
• 15.5. Market Trends
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Players - Intensity Mapping
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. China Irritable Bowel Syndrome Treatment Market Analysis
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Indication
      • 15.8.1.2.3. By Distribution Channel
  • 15.8.2. Japan Irritable Bowel Syndrome Treatment Market Analysis
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Indication
      • 15.8.2.2.3. By Distribution Channel
  • 15.8.3. South Korea Irritable Bowel Syndrome Treatment Market Analysis
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Indication
      • 15.8.3.2.3. By Distribution Channel

16. South Asia Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
• 16.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
  • 16.3.1. By Country
    • 16.3.1.1. India
    • 16.3.1.2. Indonesia
    • 16.3.1.3. Malaysia
    • 16.3.1.4. Thailand
    • 16.3.1.5. Rest of South Asia
  • 16.3.2. By Product
  • 16.3.3. By Indication
  • 16.3.4. By Distribution Channel
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Indication
  • 16.4.4. By Distribution Channel
• 16.5. Market Trends
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Players - Intensity Mapping
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. India Irritable Bowel Syndrome Treatment Market Analysis
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Indication
      • 16.8.1.2.3. By Distribution Channel
  • 16.8.2. Indonesia Irritable Bowel Syndrome Treatment Market Analysis
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Indication
      • 16.8.2.2.3. By Distribution Channel
  • 16.8.3. Malaysia Irritable Bowel Syndrome Treatment Market Analysis
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Indication
      • 16.8.3.2.3. By Distribution Channel
  • 16.8.4. Thailand Irritable Bowel Syndrome Treatment Market Analysis
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Indication
      • 16.8.4.2.3. By Distribution Channel

17. Oceania Irritable Bowel Syndrome Treatment Market 2016-2023 and Forecast 2023-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
• 17.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
  • 17.3.1. By Country
    • 17.3.1.1. Australia
    • 17.3.1.2. New Zealand
  • 17.3.2. By Product
  • 17.3.3. By Indication
  • 17.3.4. By Distribution Channel
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Indication
  • 17.4.4. By Distribution Channel
• 17.5. Market Trends
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Players - Intensity Mapping
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. Australia Irritable Bowel Syndrome Treatment Market Analysis
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Indication
      • 17.8.1.2.3. By Distribution Channel
  • 17.8.2. New Zealand Irritable Bowel Syndrome Treatment Market Analysis
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Indication
      • 17.8.2.2.3. By Distribution Channel

18. Middle East and Africa (MEA) Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2016-2022
• 18.3. Current and Future Market Value (US$ Mn) Analysis and Forecast Analysis By Market Taxonomy, 2023-2033
  • 18.3.1. By Country
    • 18.3.1.1. GCC Countries
    • 18.3.1.2. Turkey
    • 18.3.1.3. North Africa
    • 18.3.1.4. South Africa
    • 18.3.1.5. Rest of Middle East and Africa
  • 18.3.2. By Product
  • 18.3.3. By Indication
  • 18.3.4. By Distribution Channel
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Product
  • 18.4.3. By Indication
  • 18.4.4. By Distribution Channel
• 18.5. Market Trends
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Players - Intensity Mapping
• 18.8. Country Level Analysis & Forecast
  • 18.8.1. GCC Countries Irritable Bowel Syndrome Treatment Market Analysis
    • 18.8.1.1. Introduction
    • 18.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.1.2.1. By Product
      • 18.8.1.2.2. By Indication
      • 18.8.1.2.3. By Distribution Channel
  • 18.8.2. Turkey Irritable Bowel Syndrome Treatment Market Analysis
    • 18.8.2.1. Introduction
    • 18.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.2.2.1. By Product
      • 18.8.2.2.2. By Indication
      • 18.8.2.2.3. By Distribution Channel
  • 18.8.3. South Africa Irritable Bowel Syndrome Treatment Market Analysis
    • 18.8.3.1. Introduction
    • 18.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.3.2.1. By Product
      • 18.8.3.2.2. By Indication
      • 18.8.3.2.3. By Distribution Channel
  • 18.8.4. North Africa Irritable Bowel Syndrome Treatment Market Analysis
    • 18.8.4.1. Introduction
    • 18.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 18.8.4.2.1. By Product
      • 18.8.4.2.2. By Indication
      • 18.8.4.2.3. By Distribution Channel

19. Market Structure Analysis

• 19.1. Market Analysis by Tier of Companies
• 19.2. Market Share Analysis of Top Players
• 19.3. Market Presence Analysis

20. Competition Analysis

• 20.1. Competition Dashboard
• 20.2. Competition Deep Dive
  • 20.2.1. Pfizer, Inc.
    • 20.2.1.1. Overview
    • 20.2.1.2. Product Portfolio
    • 20.2.1.3. Sales Footprint
    • 20.2.1.4. Key Financials
    • 20.2.1.5. SWOT Analysis
    • 20.2.1.6. Strategy Overview
      • 20.2.1.6.1. Marketing Strategy
      • 20.2.1.6.2. Product Strategy
      • 20.2.1.6.3. Channel Strategy
  • 20.2.2. Takeda Pharmaceutical Company Limited
    • 20.2.2.1. Overview
    • 20.2.2.2. Product Portfolio
    • 20.2.2.3. Sales Footprint
    • 20.2.2.4. Key Financials
    • 20.2.2.5. SWOT Analysis
    • 20.2.2.6. Strategy Overview
      • 20.2.2.6.1. Marketing Strategy
      • 20.2.2.6.2. Product Strategy
      • 20.2.2.6.3. Channel Strategy
  • 20.2.3. Abbott Laboratories
    • 20.2.3.1. Overview
    • 20.2.3.2. Product Portfolio
    • 20.2.3.3. Sales Footprint
    • 20.2.3.4. Key Financials
    • 20.2.3.5. SWOT Analysis
    • 20.2.3.6. Strategy Overview
      • 20.2.3.6.1. Marketing Strategy
      • 20.2.3.6.2. Product Strategy
      • 20.2.3.6.3. Channel Strategy
  • 20.2.4. Novartis AG
    • 20.2.4.1. Overview
    • 20.2.4.2. Product Portfolio
    • 20.2.4.3. Sales Footprint
    • 20.2.4.4. Key Financials
    • 20.2.4.5. SWOT Analysis
    • 20.2.4.6. Strategy Overview
      • 20.2.4.6.1. Marketing Strategy
      • 20.2.4.6.2. Product Strategy
      • 20.2.4.6.3. Channel Strategy
  • 20.2.5. AstraZeneca PLC
    • 20.2.5.1. Overview
    • 20.2.5.2. Product Portfolio
    • 20.2.5.3. Sales Footprint
    • 20.2.5.4. Key Financials
    • 20.2.5.5. SWOT Analysis
    • 20.2.5.6. Strategy Overview
      • 20.2.5.6.1. Marketing Strategy
      • 20.2.5.6.2. Product Strategy
      • 20.2.5.6.3. Channel Strategy
  • 20.2.6. Ironwood Pharmaceuticals Inc. and Allergan Plc
    • 20.2.6.1. Overview
    • 20.2.6.2. Product Portfolio
    • 20.2.6.3. Sales Footprint
    • 20.2.6.4. Key Financials
    • 20.2.6.5. SWOT Analysis
    • 20.2.6.6. Strategy Overview
      • 20.2.6.6.1. Marketing Strategy
      • 20.2.6.6.2. Product Strategy
      • 20.2.6.6.3. Channel Strategy
  • 20.2.7. Bausch Health Companies Inc.
    • 20.2.7.1. Overview
    • 20.2.7.2. Product Portfolio
    • 20.2.7.3. Sales Footprint
    • 20.2.7.4. Key Financials
    • 20.2.7.5. SWOT Analysis
    • 20.2.7.6. Strategy Overview
      • 20.2.7.6.1. Marketing Strategy
      • 20.2.7.6.2. Product Strategy
      • 20.2.7.6.3. Channel Strategy
  • 20.2.8. GlaxoSmithKline, Plc.
    • 20.2.8.1. Overview
    • 20.2.8.2. Product Portfolio
    • 20.2.8.3. Sales Footprint
    • 20.2.8.4. Key Financials
    • 20.2.8.5. SWOT Analysis
    • 20.2.8.6. Strategy Overview
      • 20.2.8.6.1. Marketing Strategy
      • 20.2.8.6.2. Product Strategy
      • 20.2.8.6.3. Channel Strategy
  • 20.2.9. Lexicon Pharmaceuticals, Inc.
    • 20.2.9.1. Overview
    • 20.2.9.2. Product Portfolio
    • 20.2.9.3. Sales Footprint
    • 20.2.9.4. Key Financials
    • 20.2.9.5. SWOT Analysis
    • 20.2.9.6. Strategy Overview
      • 20.2.9.6.1. Marketing Strategy
      • 20.2.9.6.2. Product Strategy
      • 20.2.9.6.3. Channel Strategy
  • 20.2.10. Sucampo Pharmaceuticals, Inc.
    • 20.2.10.1. Overview
    • 20.2.10.2. Product Portfolio
    • 20.2.10.3. Sales Footprint
    • 20.2.10.4. Key Financials
    • 20.2.10.5. SWOT Analysis
    • 20.2.10.6. Strategy Overview
      • 20.2.10.6.1. Marketing Strategy
      • 20.2.10.6.2. Product Strategy
      • 20.2.10.6.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

List of Tables

• Table 01: Global Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033, By Product
• Table 02: Global Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033by Indication
• Table 03: Global Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel
• Table 04: Global Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033, By Region
• Table 05: North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Country
• Table 06: North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Product
• Table 07: North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Indication
• Table 08: North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel
• Table 09: Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Country
• Table 10: Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Product
• Table 11: Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Indication
• Table 12: Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel
• Table 13: Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Country
• Table 14: Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Product
• Table 15: Europe Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033by Indication
• Table 16: Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel
• Table 17: East Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Country
• Table 18: East Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Product
• Table 19: East Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Indication
• Table 20: East Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel
• Table 21: South Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Country
• Table 22: South Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Product
• Table 23: South Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Indication
• Table 24: South Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel
• Table 25: Oceania Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Country
• Table 26: Oceania Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Product
• Table 27: Oceania Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033by Indication
• Table 28: Oceania Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel
• Table 29: Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Country
• Table 30: Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Product
• Table 31: Middle East & Africa Irritable Bowel Syndrome Treatment Market Analysis 2016-2022 and Forecast 2023-2033by Indication
• Table 32: Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis 2016-2022 and Forecast 2023-2033, By Distribution Channel

List of Figures

• Figure 01: Global Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016-2022
• Figure 02: Global Irritable Bowel Syndrome Treatment M arket Forecast & Y-O-Y Growth, 2023-2033
• Figure 03: Global Irritable Bowel Syndrome Treatment Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2033
• Figure 04: Global Irritable Bowel Syndrome Treatment Market Value Share (%) Analysis 2023 and 2033, By Product
• Figure 05: Global Irritable Bowel Syndrome Treatment Market Y-O-Y Growth (%) Analysis 2022-2033, By Product
• Figure 06: Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis 2023-2033, By Product
• Figure 07: Global Irritable Bowel Syndrome Treatment Market Value Share (%) Analysis 2023 and 2033, By Indication
• Figure 08: Global Irritable Bowel Syndrome Treatment Market Y-O-Y Growth (%) Analysis 2022-2033, By Indication
• Figure 09: Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis 2023-2033, By Indication
• Figure 10: Global Irritable Bowel Syndrome Treatment Market Value Share (%) Analysis 2023 and 2033, By Distribution Channel
• Figure 11: Global Irritable Bowel Syndrome Treatment Market Y-O-Y Growth (%) Analysis 2022-2033, By Distribution Channel
• Figure 12: Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis 2023-2033, By Distribution Channel
• Figure 13: Global Irritable Bowel Syndrome Treatment Market Value Share (%) Analysis 2023 and 2033, By Region
• Figure 14: Global Irritable Bowel Syndrome Treatment Market Y-O-Y Growth (%) Analysis 2022-2033, By Region
• Figure 15: Global Irritable Bowel Syndrome Treatment Market Attractiveness Analysis 2023-2033, By Region
• Figure 16: North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016-2022
• Figure 17: North America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Forecast, 2023-2033
• Figure 18: North America Irritable Bowel Syndrome Treatment Market Value Share, By Product (2023 E)
• Figure 19: North America Irritable Bowel Syndrome Treatment Market Value Share, By Indication (2023 E)
• Figure 20: North America Irritable Bowel Syndrome Treatment Market Value Share, By Distribution Channel (2023 E)
• Figure 21: North America Irritable Bowel Syndrome Treatment Market Value Share, By Country (2023 E)
• Figure 22: North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Product, 2023-2033
• Figure 23: North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Indication, 2023-2033
• Figure 24: North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Distribution Channel, 2023-2033
• Figure 25: North America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Country, 2023-2033
• Figure 26: U.S. Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 27: Global Vs. U.S. Growth Comparison, 2022 - 2033
• Figure 28: U.S. Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 29: U.S. Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 30: U.S. Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 31: Canada Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 32: Global Vs. Canada. Growth Comparison, 2022 - 2033
• Figure 33: Canada Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 34: Canada Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 35: Canada Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 36: Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016-2022
• Figure 37: Latin America Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Forecast, 2023-2033
• Figure 38: Latin America Irritable Bowel Syndrome Treatment Market Value Share, By Product (2023 E)
• Figure 39: Latin America Irritable Bowel Syndrome Treatment Market Value Share, By Indication (2023 E)
• Figure 40: Latin America Irritable Bowel Syndrome Treatment Market Value Share, By Distribution Channel (2023 E)
• Figure 41: Latin America Irritable Bowel Syndrome Treatment Market Value Share, By Country (2023 E)
• Figure 42: Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Product, 2023-2033
• Figure 43: Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Indication, 2023-2033
• Figure 44: Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Distribution Channel, 2023-2033
• Figure 45: Latin America Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Country, 2023-2033
• Figure 46: Mexico Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 47: Global Vs Mexico Growth Comparison, 2022 - 2033
• Figure 48: Mexico Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 49: Mexico Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 50: Mexico Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 51: Brazil Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 52: Global Vs. Brazil. Growth Comparison, 2022 - 2033
• Figure 53: Brazil Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 54: Brazil Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 55: Brazil Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 56: Argentina Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 57: Global Vs Argentina Growth Comparison, 2022 - 2033
• Figure 58: Argentina Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 59: Argentina Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 60: Argentina Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 61: Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016-2022
• Figure 62: Europe Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Forecast, 2023-2033
• Figure 63: Europe Irritable Bowel Syndrome Treatment Market Value Share, By Product (2023 E)
• Figure 64: Europe Irritable Bowel Syndrome Treatment Market Value Share, By Indication (2023 E)
• Figure 65: Europe Irritable Bowel Syndrome Treatment Market Value Share, By Distribution Channel (2023 E)
• Figure 66: Europe Irritable Bowel Syndrome Treatment Market Value Share, By Country (2023 E)
• Figure 67: Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Product, 2023-2033
• Figure 68: Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Indication, 2023-2033
• Figure 69: Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Distribution Channel, 2023-2033
• Figure 70: Europe Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Country, 2023-2033
• Figure 71: UK Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 72: Global Vs. UK Growth Comparison, 2022 - 2033
• Figure 73: UK Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 74: UK Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 75: UK Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 76: Germany Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 77: Global Vs. Germany Growth Comparison, 2022 - 2033
• Figure 78: Germany Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 79: Germany Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 80: Germany Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 81: Italy Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 82: Global Vs. Italy Growth Comparison, 2022 - 2033
• Figure 83: Italy Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 84: Italy Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 85: Italy Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 86: France Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 87: Global Vs France Growth Comparison, 2022 - 2033
• Figure 88: France Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 89: France Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 90: France Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 91: Spain Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 92: Global Vs Spain Growth Comparison, 2022 - 2033
• Figure 93: Spain Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 94: Spain Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 95: Spain Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 96: Russia Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 97: Global Vs Russia Growth Comparison, 2022 - 2033
• Figure 98: Russia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 99: Russia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 100: Russia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 101: Benelux Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 102: Global Vs Benelux Growth Comparison, 2022 - 2033
• Figure 103: Benelux Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 104: Benelux Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 105: Benelux Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 106: East Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016-2022
• Figure 107: East Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Forecast, 2023-2033
• Figure 108: East Asia Irritable Bowel Syndrome Treatment Market Value Share, By Product (2023 E)
• Figure 109: East Asia Irritable Bowel Syndrome Treatment Market Value Share, By Indication (2023 E)
• Figure 110: East Asia Irritable Bowel Syndrome Treatment Market Value Share, By Distribution Channel (2023 E)
• Figure 111: East Asia Irritable Bowel Syndrome Treatment Market Value Share, By Country (2023 E)
• Figure 112: East Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Product, 2023-2033
• Figure 113: East Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Indication, 2023-2033
• Figure 114: East Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Distribution Channel, 2023-2033
• Figure 115: East Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Country, 2023-2033
• Figure 116: China Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 117: Global Vs. China Growth Comparison, 2022 - 2033
• Figure 118: China Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 119: China Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 120: China Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 121: Japan Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 122: Global Vs. Japan Growth Comparison, 2022 - 2033
• Figure 123: Japan Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 124: Japan Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 125: Japan Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 126: South Korea Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 127: Global Vs South Korea Growth Comparison, 2022 - 2033
• Figure 128: South Korea Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 129: South Korea Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 130: South Korea Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 131: South Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016-2022
• Figure 132: South Asia Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Forecast, 2023-2033
• Figure 133: South Asia Irritable Bowel Syndrome Treatment Market Value Share, By Product (2023 E)
• Figure 134: South Asia Irritable Bowel Syndrome Treatment Market Value Share, By Indication (2023 E)
• Figure 135: South Asia Irritable Bowel Syndrome Treatment Market Value Share, By Distribution Channel (2023 E)
• Figure 136: South Asia Irritable Bowel Syndrome Treatment Market Value Share, By Country (2023 E)
• Figure 137: South Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Product, 2023-2033
• Figure 138: South Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Indication, 2023-2033
• Figure 139: South Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Distribution Channel, 2023-2033
• Figure 140: South Asia Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Country, 2023-2033
• Figure 141: India Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 142: Global Vs. India Growth Comparison, 2022 - 2033
• Figure 143: India Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 144: India Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 145: India Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 146: Indonesia Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 147: Global Vs. Indonesia Growth Comparison, 2022 - 2033
• Figure 148: Indonesia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 149: Indonesia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 150: Indonesia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 151: Malaysia Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 152: Global Vs. Malaysia Growth Comparison, 2022 - 2033
• Figure 153: Malaysia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 154: Malaysia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 155: Malaysia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 156: Thailand Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 157: Global Vs. Thailand Growth Comparison, 2022 - 2033
• Figure 158: Thailand Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 159: Thailand Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 160: Thailand Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 161: Oceania Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016-2022
• Figure 162: Oceania Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Forecast, 2023-2033
• Figure 163: Oceania Irritable Bowel Syndrome Treatment Market Value Share, By Product (2023 E)
• Figure 164: Oceania Irritable Bowel Syndrome Treatment Market Value Share, By Indication (2023 E)
• Figure 165: Oceania Irritable Bowel Syndrome Treatment Market Value Share, By Distribution Channel (2023 E)
• Figure 166: Oceania Irritable Bowel Syndrome Treatment Market Value Share, By Country (2023 E)
• Figure 167: Oceania Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Product, 2023-2033
• Figure 168: Oceania Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Indication, 2023-2033
• Figure 169: Oceania Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Distribution Channel, 2023-2033
• Figure 170: Oceania Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Country, 2023-2033
• Figure 171: Australia Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 172: Global Vs. Australia Growth Comparison, 2022 - 2033
• Figure 173: Australia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 174: Australia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 175: Australia Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 176: New Zealand Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 177: Global Vs New Zealand Growth Comparison, 2022 - 2033
• Figure 178: New Zealand Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 179: New Zealand Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 180: New Zealand Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 181: Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Analysis, 2016-2022
• Figure 182: Middle East & Africa Irritable Bowel Syndrome Treatment Market Value (US$ Mn) Forecast, 2023-2033
• Figure 183: Middle East & Africa Irritable Bowel Syndrome Treatment Market Value Share, By Product (2023 E)
• Figure 184: Middle East & Africa Irritable Bowel Syndrome Treatment Market Value Share, By Indication (2023 E)
• Figure 185: Middle East & Africa Irritable Bowel Syndrome Treatment Market Value Share, By Distribution Channel (2023 E)
• Figure 186: Middle East & Africa Irritable Bowel Syndrome Treatment Market Value Share, By Country (2023 E)
• Figure 187: Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Product, 2023-2033
• Figure 188: Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Indication, 2023-2033
• Figure 189: Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Distribution Channel, 2023-2033
• Figure 190: Middle East & Africa Irritable Bowel Syndrome Treatment Market Attractiveness Analysis By Country, 2023-2033
• Figure 191: GCC Countries Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 192: Global Vs GCC Countries Growth Comparison, 2022 - 2033
• Figure 193: GCC Countries Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 194: GCC Countries Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 195: GCC Countries Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 196: Turkey Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 197: Global Vs. Turkey Growth Comparison, 2022 - 2033
• Figure 198: Turkey Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 199: Turkey Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 200: Turkey Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 201: South Africa Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 202: Global Vs. South Africa Growth Comparison, 2022 - 2033
• Figure 203: South Africa Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 204: South Africa Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 205: South Africa Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033
• Figure 206: North Africa Irritable Bowel Syndrome Treatment Market Value Proportion Analysis, 2022
• Figure 207: Global Vs North Africa Growth Comparison, 2022 - 2033
• Figure 208: North Africa Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Product, 2022 & 2033
• Figure 209: North Africa Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Indication, 2022 & 2033
• Figure 210: North Africa Irritable Bowel Syndrome Treatment Market Share Analysis (%) By Distribution Channel, 2022 & 2033